Dr. Nadav Klein is a Principal at Triventures. He brings years of experience in building, managing and nurturing technology driven teams and start-ups in the information technology and life science industries.
His keen interest and proficiency in artificial intelligence, bioinformatics and healthcare applications allowed for a rich academic background, spanning a wide range of multifaceted research fields, most notably computational biology, genomics, robotics, precision medicine and even precision agriculture.
Nadav’s unique skill set comprised of technological and data adeptness as well as deep scientific and biological dexterity and know-how, has led him to hold several R&D leadership roles.
He recently served as CTO of VLX Ventures, an Israeli technology incubator, where he led all operations, from scouting and assessing new technologies, through due diligence processes, to working alongside the incubator’s portfolio companies. In this capacity, Nadav has also led commercialization processes with various Technology Transfer Offices, as well as internal venture creation initiatives. Nadav additionally holds board and advisory board positions with several companies.
Nadav previously served as the Co-Founder and CEO of Omix.ai, Co-Founder and CTO of Nuclei.ai (acquired) and Co-Founder and CTO of Sync.ai (acquired). Prior to becoming an entrepreneur, Nadav was an R&D leader for LoyalBlocks (acquired), as well as a group leader at SAP and Radvision (acquired).
He holds a PhD in Bioinformatics from the University of California, Davis and a BSc in Bioinformatics from Tel Aviv University. He shares his knowledge as a lecturer at Tel Aviv University, the Technion and the Interdisciplinary Center (IDC) in Herzliya.